ISRG Stock Analysis: Buy, Sell, or Hold?
ISRG - Intuitive Surgical Inc.
$366.70
-3.13 (-0.85%)
âŧ
5d:
-1.58%
30d:
-1.88%
90d:
-13.12%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Get Alerted When ISRG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ISRG is fairly priced but lacks strong directional signals. At -9.9% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ISRG is fairly priced but lacks strong directional signals. At -9.9% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$440.63
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$273.60
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ISRG is currently trading at $366.70, which is considered slightly low relative to its 30-day fair value range of $361.95 to $390.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.4) compared to its historical average (41.5). Remarkably, the market is currently pricing in an annual earnings decline of 9.9% over the next few years. This pessimistic expectation contrasts with the company's recent 26.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $363.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $478.01 (+30.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISRG is in a strong downtrend. The price is currently testing key support at $363.23. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $478.01 (+30.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$361.95 -
$390.29
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding ISRG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.4% below Wall St target ($478.01)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$361.95 -
$390.29
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$363.23
Resistance Level
$384.06
Current Trend
Strong Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.38
Wall Street Target
$478.01
(+30.4%)
Revenue Growth (YoY)
18.5%
Earnings Growth (YoY)
26.5%
Profit Margin
28.4%
Valuation Discount vs History
-9.9% cheaper
PE vs Historical
30.4 vs 41.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.9%
(market-implied from PE analysis)
1-Year Target
$330.40
(-10%)
2-Year Target
$297.69
(-19%)
3-Year Target
$268.22
(-27%)
3-Yr Target (if PE normalizes)
(PE: 30â42)
$366.40
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.4, Growth: 11.8%)
$512.71
(+40%)
Base:
(SPY PE: 20.2, Growth: 11.8%)
$341.43
(-7%)
Bear:
(PE: 17.2, Growth: 11.8%)
$290.21
(-21%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Trailing PE: 42.75 | Current EPS (TTM): $8.65
Bull Case
$567.69
(+55%)
Analyst growth 39.5%, PE expands to 47.0
Base Case
$516.09
(+41%)
Market implied 39.5%, PE stable at 42.8
Bear Case
$251.48
(-31%)
Severe decline -20.0%, PE contracts to 36.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.4 to 41.5
Stabilization Target:
$500.94
(+36.6%)
PE Expansion Potential:
+36.6%
Share & Embed Analysis
Last updated: September 05, 2026 6:24 AM ET
Data refreshes hourly during market hours. Next update: 7:24 AM
Data refreshes hourly during market hours. Next update: 7:24 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISRG showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-03-23
Myriam Curet
SELL
105 shares
2026-03-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 47 HOLD |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 43 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$209 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 47 HOLD |
Advanced ISRG Option Strategies
Professional options setups generated by AI based on today's ISRG price and gamma walls.
